16 June 2025
- Title: Exploring Strategies to Improve the In Vivo Cardiovascular Safety Evaluation of New Drugs
- Author: Elham Ataei Alizadeh, University of Antwerp & Boehringer Ingelheim
- Supervisors: Prof. Pieter-Jan Guns (University of Antwerp), Prof. Dr. Guido De Meyer (University of Antwerp), and Dr. Brian Guth (Boehringer Ingelheim Pharma GmbH & Co KG)
16 December 2024
- Title: Modeling and numerical simulation applied to the prediction of the effect of drugs in the cardiovascular system
- Author: Sara Costa Faya, Inria and Sorbonne University
- Supervisors: Dr. Miguel A. Fernández, Dr. Damiano Lombardi, and Dr. Marina Vidrascu (Inriaand Sorbonne University)
2 May 2024
- Title: Empowering Predictivity and Speed of hiPSC CM Assays by Machine Learning Approaches
- Author: Haibo Liu, Notocord, Inria, Sorbonne University
- Supervisors: Dr. Sylvain Bernasconni (Notocord), Dr. Damiano Lombardi (Inria), Prof. Muriel Boulakia (Sorbonne University)
12 December 2023
- Title: Cardiovascular safety liabilities of VEGFR-2 inhibitors
- Author: Patrizia Pannucci, University of Nottingham
- Supervisors: Prof. Jeanette Woolard and Prof. Steve Hill, University of Nottingham
17 November 2023
- Title: The Safety Pharmacology of Syk inhibitors: New preclinical screens to characterise cardiovascular adverse drug effects.
- Author: Marieke Van Daele, University of Nottingham
- Supervisors: Prof. Jeanette Woolard and Prof. Steve Hill, University of Nottingham